7.5.2FCA_IISection
Pharmacology
lines 3706–3706id: 7.5.2
7 items
- 7.5.2.1FCA_IIPharmacology of oxytocic agents with special reference to oxytocin derivatives (including carbetocin), ergot derivatives and prostaglandins
- 7.5.2.2FCA_IIPharmacology of tocolytic agents, with specific reference to beta-2 agonists, calcium antagonists, magnesium, inhalational anaesthetics, nitrates and non-steroidal anti- inflammatory medications (NSAIDs)
- 7.5.2.3FCA_IIPharmacology of agents used for the treatment of preeclampsia, including nifedipine, magnesium, hydralazine, labetalol and other antihypertensives
- 7.5.2.4FCA_IIFactors that influence the transfer of medications across the placenta and into breast milk
- 7.5.2.5FCA_IIPotential effects on the foetus and neonate of medications administered during pregnancy
- 7.5.2.6FCA_IIMinimum alveolar concentration (MAC) and local anaesthetic adjustments during pregnancy
- 7.5.2.7FCA_IIMedications for hypotension management, including neuraxial-induced hypotension